专利快速检索-快速检索全球专利，免费商用专利数据库-IPRDB

1. 发明授权

US4285207A Air conditioning apparatus comprising refrigerant shortage sensor 失效
标题翻译：空调装置包括制冷剂不足传感器
公开(公告)号：US4285207A
公开(公告)日：1981-08-25
申请号：US59723
申请日：1979-07-23
申请人： Hiroyuki Sugiura , Ryota Hasegawa , Teruo Nakamura
发明人： Hiroyuki Sugiura , Ryota Hasegawa , Teruo Nakamura
IPC分类号： B60H1/32 , F25B49/00 , G01F23/74 , G05D23/275 , B60H3/04 , G05D23/32
CPC分类号： G05D23/275 , B60H1/3225 , F25B49/005 , G01F23/74 , F25B2500/222 , F25B2700/04
摘要： A float operated switch (21) is actuated when the level of refrigerant fluid in a reservoir (11) is below a predetermined value to produce an electrical signal. The signal is delayed by 10 to 30 seconds and applied to a switch circuit (54) to disengage an electromagnetic clutch (63) and thereby de-energize a compressor (64). The clutch (63) is also disengaged by the action of a thermal switch (61) when the temperature in a space which is being air conditioned drops below a predetermined value. The operation of the float operated switch (21) is inhibited when the sensed temperature is below the predetermined value and also when a motor which drives the compressor (64) is not operating to prevent erroneous de-energization of the compressor (64).
摘要翻译：当储存器（11）中的制冷剂流体的水平低于预定值时，浮动操作开关（21）被致动以产生电信号。信号被延迟10至30秒，并施加到开关电路（54）以使电磁离合器（63）脱离，从而使压缩机（64）断电。当被空调的空间中的温度下降到预定值以下时，离合器（63）也通过热开关（61）的作用而脱离。当感测到的温度低于预定值时，以及当驱动压缩机（64）的电动机不工作以防止压缩机（64）的错误断电时，禁止浮动操作开关（21）的操作。

2. 发明授权

US07767806B2 Hyaluronic acid modification products and drug carriers using them 有权
标题翻译：透明质酸改性产品和使用它们的药物载体
公开(公告)号：US07767806B2
公开(公告)日：2010-08-03
申请号：US10571005
申请日：2004-09-08
申请人： Tai Hirakura , Teruo Nakamura , Tsuyoshi Shimoboji
发明人： Tai Hirakura , Teruo Nakamura , Tsuyoshi Shimoboji
IPC分类号： C07H5/04 , C07H1/00 , A61K31/728
CPC分类号： A61K9/5153 , A61K9/5161 , C08B37/0072 , C08G63/912
摘要： A hyaluronic acid modification product includes a polymer bonded to hyaluronic acid, the polymer being polylactic acid, polyglycolic acid or lactic acid-glycolic acid copolymer, providing a drug carrier which efficiently encapsulates low molecular weight drugs and provides sustained-release over a long term, control of blood residence, is well dispersible in an aqueous solution, and has excellent biocompatibility.
摘要翻译：透明质酸改性产品包括与透明质酸结合的聚合物，聚合物是聚乳酸，聚乙醇酸或乳酸 - 乙醇酸共聚物，提供有效地包封低分子量药物并长期持续释放的药物载体，血液停留的控制在水溶液中分散性良好，生物相容性优异。

3. 发明申请

US20090193826A1 Refrigerator 失效
标题翻译：冰箱
公开(公告)号：US20090193826A1
公开(公告)日：2009-08-06
申请号：US11666247
申请日：2005-09-07
申请人： Kenji Yasugi , Teruo Nakamura , Tsuyoshi Shimoboji , Mika Sato
发明人： Kenji Yasugi , Teruo Nakamura , Tsuyoshi Shimoboji , Mika Sato
IPC分类号： F25B29/00 , F25D19/00 , F25D11/02
CPC分类号： F25D23/12 , F25D11/02 , F25D17/065 , F25D31/005 , F25D2317/061 , F25D2400/02 , F25D2400/16
摘要： There is provided a temperature switching compartment 3 which can switch the internal temperature thereof between a low temperature side at which a storage material is kept in cold storage and a high temperature side maintained at 50° C., to 80° C. at which cooked food is kept warm, by cooling with a cooler 17 and heating with a heater 15.
摘要翻译：设置有一个温度切换室3，其可以将保存在冷藏中的储存材料的低温侧和保持在50℃的高温侧的低温侧切换到80℃的熟化温度通过用冷却器17冷却并用加热器15加热来保持食物温暖。

4. 发明申请

US20090082266A1 CONJUGATE OF WATER-SOLUBLE HYALURONIC ACID MODIFICATION PRODUCT WITH GLP-A ANALOGUE 审中-公开
标题翻译：具有GLP-A类似物的水溶性羟尿酸改性产品的结合
公开(公告)号：US20090082266A1
公开(公告)日：2009-03-26
申请号：US11908278
申请日：2006-03-08
申请人： Teruo Nakamura , Tatsuya Kato , Hideyuki Togawa , Kenji Yasugi , Hiroko Konishi , Yasuo Sekimori , Tsuyoshi Shimoboji
发明人： Teruo Nakamura , Tatsuya Kato , Hideyuki Togawa , Kenji Yasugi , Hiroko Konishi , Yasuo Sekimori , Tsuyoshi Shimoboji
IPC分类号： A61K38/17 , A61P3/00
CPC分类号： C07K14/605 , A61K47/61 , C08B37/0072
摘要： To provide a GLP-1 analogue long-acting prophylactic or therapeutic agent for diabetes, diabetic complications and/or obesity due to diabetes which provides an extended half-life of a GLP-1 analogue in the blood to prevent frequent administration, and is biodegradable and safe.The present invention provides a conjugate obtained by binding, to a GLP-1 analogue into which a mercapto group is incorporated, water soluble hyaluronic acid modification product obtained by incorporating a substituent via an amide bond to the carboxyl group of glucuronic acid portion of hyaluronic acid as a derivative thereof, using a specific condensing agent in an aprotic polar solvent; and a prophylactic or therapeutic agent having a durable blood glucose lowering effect for diabetes, diabetic complications or obesity.
摘要翻译：提供GLP-1类似物长效预防或治疗糖尿病，由于糖尿病导致的糖尿病并发症和/或肥胖症，其提供血液中GLP-1类似物的延长半衰期以防止频繁施用，并且是可生物降解的安全。本发明提供了通过与其中引入巯基的GLP-1类似物结合获得的缀合物，其通过将酰胺键引入到透明质酸的葡萄糖醛酸部分的羧基而获得的水溶性透明质酸改性产物作为其衍生物，在非质子极性溶剂中使用特定的缩合剂; 以及对糖尿病，糖尿病并发症或肥胖具有持久的血糖降低作用的预防或治疗剂。

5. 发明申请

US20070031503A1 Hyaluronic acid modification products and drug carrier therefrom 有权
标题翻译：透明质酸改性产品和药物载体
公开(公告)号：US20070031503A1
公开(公告)日：2007-02-08
申请号：US10571005
申请日：2004-09-08
申请人： Tai Hirakura , Teruo Nakamura
发明人： Tai Hirakura , Teruo Nakamura
IPC分类号： A61K9/50 , C08B37/00 , C08G63/91 , A61K9/16
CPC分类号： A61K9/5153 , A61K9/5161 , C08B37/0072 , C08G63/912
摘要： There is provided a drug carrier which has solved the problems of conventional drug carriers, which can encapsulate a low molecular drug efficiently, which can control a sustained release period for a long term, which can control blood residence, which has high dispersibility in an aqueous solution, and which is not problematical in safety. A drug carrier, which comprises injectable fine particles minimal in agglomeration between the particles, and which has excellent biocompatibility, is also provided. A hyaluronic acid modification product comprising hyaluronic acid or its derivative, and a polymer bonded together, the polymer being selected from polylactic acid, polyglycolic acid and lactic acid-glycolic acid copolymer, according to the present invention, provides a drug carrier which encapsulates a low molecular drug efficiently, which can control a sustained release period for a long term, which can control blood residence, which is well dispersible in an aqueous solution, and which is not problematical in safety. The hyaluronic acid modification product of the present invention also provides a drug carrier comprising injectable fine particles minimal in agglomeration between the particles, and having excellent biocompatibility.
摘要翻译：提供了能够有效地包封低分子药物的常规药物载体的问题的药物载体，其可以长期控制持续释放时间，其可以控制血液存留，其在水性中具有高分散性解决方案，这在安全性上没有问题。还提供了一种药物载体，其包含颗粒之间附聚最少的可注射的微粒，并且其具有优异的生物相容性。根据本发明的包含透明质酸或其衍生物的透明质酸改性产品和结合在一起的聚合物，聚合物选自聚乳酸，聚乙醇酸和乳酸 - 乙醇酸共聚物，提供了一种药物载体，其包封低分子药物有效地控制长期的持续释放期，其可以控制在水溶液中良好分散的血液停留，并且这在安全性方面没有问题。本发明的透明质酸改性产品还提供了一种药物载体，其包含颗粒之间最少聚集的可注射的微粒，并且具有优异的生物相容性。

6. 发明授权

US5030325A Method of manufacturing gloss paper 失效
标题翻译：光泽纸的制造方法
公开(公告)号：US5030325A
公开(公告)日：1991-07-09
申请号：US369631
申请日：1989-06-21
申请人： Soichi Saji , Tatsuya Nakabai , Teruo Nakamura
发明人： Soichi Saji , Tatsuya Nakabai , Teruo Nakamura
IPC分类号： D21H19/38 , D21H19/42 , D21H19/50 , D21H19/58 , D21H19/60 , D21H25/06
CPC分类号： D21H19/50 , D21H19/38 , D21H19/42 , D21H19/58 , D21H19/60 , D21H25/06
摘要： A method of manufacturing gloss coated paper by applying a coating composition containing a pigment and an adhesive on base paper. The pigment contains 5 to 40% by weight of satin white with an average particle diameter of 0.8 .mu.m or below and an organic pigment with an average particle diameter of 0.1 to 1.0 .mu.m and a glass transition point (Tg) of 40.degree. C. or above. The weight ratio of the satin white to the organic pigment is from 0.2/1 to 5/1. The coating composition provides a coated paper with excellent gloss and smoothness.
摘要翻译：通过在基纸上涂布含有颜料和粘合剂的涂料组合物来制造光泽涂布纸的方法。颜料含有5〜40重量％的平均粒径为0.8μm以下的缎白，平均粒径为0.1〜1.0μm，玻璃化转变点（Tg）为40℃的有机颜料或以上。缎白与有机颜料的重量比为0.2 / 1至5/1。涂料组合物提供具有优异光泽和光滑度的涂布纸。

7. 发明授权

US4717321A Vane compressor with vane back pressure adjustment 失效
标题翻译：叶片压缩机带叶片背压调节
公开(公告)号：US4717321A
公开(公告)日：1988-01-05
申请号：US874555
申请日：1986-06-16
申请人： Tsunenori Shibuya , Yutaka Ishizuka , Haruhiko Takada , Teruo Nakamura , Hidehiko Takayama
发明人： Tsunenori Shibuya , Yutaka Ishizuka , Haruhiko Takada , Teruo Nakamura , Hidehiko Takayama
IPC分类号： F04C18/344 , F01C21/08 , F04C29/02
CPC分类号： F01C21/0872
摘要： A vane compressor has a vane back pressure adjustment device including back-pressure chambers defined in a vane-supporting rotor and surrounded by vanes and side blocks secured to axial ends of a cylinder. The back-pressure chamber has axial ends disposed to follow a path against each of the side blocks when the rotor rotates. The path is divided into at least one high-pressure zone in which the vanes move across a pump outlet defined in the cylinder, and at least one normal-pressure zone which is the remainder of the path. In the normal-pressure zone, oil grooves defined in surfaces of the side blocks which face the rotor and supplied with oil from an oil sump in the vane compressor are in communication with the back-pressure chambers, to thereby maintain the oil pressure in the back-pressure chambers at a pressure level in the oil sump. In the high-pressure zone, the back-pressure chambers are out of communication with the oil grooves so that the oil fed into the back-pressure chambers is confined therein, except through a restrictor means. When the vanes move across the pump outlet, the vanes enter the high-pressure zone to trap oil in the back-pressure chambers to thereby elevate the oil pressure in the back-pressure chambers to a high level. Therefore, the vanes are prevented from being retracted deeply into vane slits in the rotor and then popping out into hitting engagement with the cylinder.
摘要翻译：叶片式压缩机具有叶片背压调节装置，该叶片背压调节装置包括限定在叶片支承转子中的背压室，并被固定在气缸的轴向端部的叶片和侧块包围。背压室具有轴向端部，当转子旋转时，轴向端部设置成沿着每个侧块的路径。该路径被分成至少一个高压区域，在该高压区域中，叶片移动通过限定在气缸中的泵出口，以及作为路径的剩余部分的至少一个正常压力区域。在正常压力区域中，限定在面向转子并且从叶片式压缩机中的油底壳供给油的侧块的表面中的油槽与背压室连通，从而将油压保持在在油底壳中处于压力水平的背压室。在高压区域中，背压室与油槽不连通，除了通过限流装置之外，供给到背压室的油被限制在其中。当叶片移动穿过泵出口时，叶片进入高压区以捕获背压室中的油，从而将背压室中的油压提升到高水平。因此，防止叶片深深地缩回到转子中的叶片狭缝中，然后弹出与滚筒的接合。

8. 发明授权

US4420538A Heat-sensitive recording materials 失效
标题翻译：热敏记录材料
公开(公告)号：US4420538A
公开(公告)日：1983-12-13
申请号：US336174
申请日：1981-12-31
申请人： Teruo Nakamura , Naoto Arai
发明人： Teruo Nakamura , Naoto Arai
IPC分类号： B41M5/337 , B41M5/30 , B41M5/333 , B41M5/18
CPC分类号： B41M5/3335 , B41M5/3336 , Y10S428/913
摘要： A heat-sensitive recording material is described comprising a support having a recording layer provided thereon, said recording layer containing (1) at least one colorless or pale-colored basic dye, (2) hydroquinone monobenzyl ether, and (3) at least one compound selected from compounds represented by the formulae (I) to (IV): ##STR1## wherein X and Y are each a chlorine atom, an alkyl group having 1 to 7 carbon atoms, a phenyl group or a benzyl group; m and n are each an integer of 0 to 3; and R.sub.1 and R.sub.2 are each a hydrogen atom, an alkyl group having 1 to 7 carbon atoms, a phenyl group or a benzyl group, or R.sub.1 and R.sub.2 may jointly form a cyclohexane ring. The heat-sensitive recording material is suitable for use in high-speed recording, e.g., high-speed facsimiles.
摘要翻译：描述了一种热敏记录材料，其包括其上设置有记录层的载体，所述记录层含有（1）至少一种无色或浅色碱性染料，（2）氢醌单苄醚，和（3）至少一种（Ⅰ）至（IV）表示的化合物的化合物：其中X和Y各自为氯原子，具有1至7个碳原子的烷基，苯基或苄基; m和n分别为0〜3的整数， R 1和R 2各自为氢原子，具有1〜7个碳原子的烷基，苯基或苄基，或者R 1和R 2可共同形成环己烷环。热敏记录材料适用于高速记录，例如高速传真机。

9. 发明授权

US4414627A Main memory control system 失效
标题翻译：主内存控制系统
公开(公告)号：US4414627A
公开(公告)日：1983-11-08
申请号：US296978
申请日：1981-08-27
申请人： Teruo Nakamura
发明人： Teruo Nakamura
IPC分类号： G06F12/16 , G06F12/06 , G06F13/00
CPC分类号： G06F12/0653
摘要： A main memory control system reconstructs the main memory following DP system failure to ensure continuous logical address to operative physical memory mapping so that the DP system can be restarted using a rescue type initial program load. An address converting table has word registers addressable by logical address for storing the respective preassigned physical unit memory addresses and corresponding flags to indicate whether the unit memories are operative. Prior to DP system restart, the words of the address converting table are shifted among the registers to reallocate the real addresses of nonfunctioning unit memories to the read address of functioning unit memories.
摘要翻译：主存储器控制系统重建DP系统故障后的主存储器，以确保连续的逻辑地址到可操作的物理存储器映射，以便DP系统可以使用救援类型的初始程序加载重新启动。地址转换表具有可通过逻辑地址寻址的字寄存器，用于存储相应的预分配的物理单元存储器地址和相应的标志，以指示单元存储器是否可操作。在DP系统重启之前，地址转换表的字在寄存器之间移位，以将非功能单元存储器的实际地址重新分配到功能单元存储器的读地址。

10. 发明授权

US08022191B2 PEG-conjugated erythropoietin 有权
标题翻译： PEG结合的促红细胞生成素
公开(公告)号：US08022191B2
公开(公告)日：2011-09-20
申请号：US11498053
申请日：2006-08-03
申请人： Teruo Nakamura , Yasuo Sekimori , Minoru Machida , Hiromitsu Kawata , Hajime Miyamoto
发明人： Teruo Nakamura , Yasuo Sekimori , Minoru Machida , Hiromitsu Kawata , Hajime Miyamoto
IPC分类号： A61K38/18
CPC分类号： C07K14/505 , A61K38/1816 , A61K47/60
摘要： The present invention provides a polyethylene glycol-conjugated erythropoietin (PEG-conjugated EPO) prepared by PEG conjugation on the lysine residue at position 52 of native erythropoietin (native EPO). In order to achieve more sustained efficacy without losing physiological activities of native EPO, a glycoprotein rich in sugar chains, there has been a need to develop a PEG-conjugated EPO with significantly sustained efficacy by introducing a controlled number of PEG molecules at controlled positions. This PEG-conjugated EPO addresses such a need and provides more sustained efficacy.
摘要翻译：本发明提供通过PEG缀合在天然促红细胞生成素（天然EPO）的52位的赖氨酸残基上制备的聚乙二醇缀合的促红细胞生成素（PEG-缀合的EPO）。为了获得更持久的功效而不损失富含糖链的糖蛋白的天然EPO的生理活性，需要通过在受控位置引入受控数量的PEG分子来开发具有显着持续功效的PEG-缀合的EPO。这种PEG结合的EPO解决了这种需要并提供更持久的功效。

你已经成功收藏专利！

检索式保存成功!

IPRDB

热门服务

关于我们

友情链接

联系方式